EU Approves TEVIMBRA for NSCLC Before WCLC 2025 Data Reveal
Final analysis of RATIONALE-315 demonstrates clear overall survival benefit in perioperative setting in resectable non-small cell lung cancer Broad EU label with nine approved indications...
